Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 2/3 2Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Stomach Neoplasms 5Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Sarcoma, Ewing 1SCLC 1Retinoblastoma 1Osteosarcoma 1Oligometastatic Disease 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1NSCLC 1Mouth Neoplasms 1Lymphoma, Follicular 1Lymphoma 1Locally Advanced Resectable Rectal Cancer 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1

Interventions

Doxorubicin 3Radiotherapy 2Drug Therapy 2pirarubicin 1pazopanib 1liposomal doxorubicin 1capmatinib 1anlotinib 1Triptorelin Pamoate 1Trabectedin 1Radiation 1Methotrexate 1Ifosfamide 1Fatty Acids, Omega-3 1Cisplatin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Sarcoma × Drug Therapy × Clear all
NCT02856048 2019-12-17

PRESOV

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Unknown
11 enrolled
LymphoidSarcoma

Lymphoma, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Pierian Biosciences

Phase 2/3 Completed
150 enrolled
BreastGynecologicSarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡